BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 28715796)

  • 21. Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription.
    Chen F; Mo J; Zhang L
    Tumour Biol; 2016 Oct; 37(10):13403-13412. PubMed ID: 27460090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel antisense long non-coding RNA SATB2-AS1 overexpresses in osteosarcoma and increases cell proliferation and growth.
    Liu SH; Zhu JW; Xu HH; Zhang GQ; Wang Y; Liu YM; Liang JB; Wang YX; Wu Y; Guo QF
    Mol Cell Biochem; 2017 Jun; 430(1-2):47-56. PubMed ID: 28190168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma.
    Zhang CL; Zhu KP; Shen GQ; Zhu ZS
    Tumour Biol; 2016 Feb; 37(2):2737-48. PubMed ID: 26408180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of 15 Antisense Long Non-Coding RNAs in Osteosarcoma.
    Rothzerg E; Ho XD; Xu J; Wood D; Märtson A; Kõks S
    Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide analyses of XRN1-sensitive targets in osteosarcoma cells identify disease-relevant transcripts containing G-rich motifs.
    Pashler AL; Towler BP; Jones CI; Haime HJ; Burgess T; Newbury SF
    RNA; 2021 Oct; 27(10):1265-1280. PubMed ID: 34266995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma.
    Ye H; Lin J; Yao X; Li Y; Lin X; Lu H
    Cell Physiol Biochem; 2018; 45(5):1904-1914. PubMed ID: 29518771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
    Li G; Liu K; Du X
    Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA DLX6-AS1/miR-129-5p/DLK1 axis aggravates stemness of osteosarcoma through Wnt signaling.
    Zhang RM; Tang T; Yu HM; Yao XD
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):260-266. PubMed ID: 30442366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding RNA HOXD-AS1 aggravates osteosarcoma carcinogenesis through epigenetically inhibiting p57 via EZH2.
    Gu W; Zhang E; Song L; Tu L; Wang Z; Tian F; Aikenmu K; Chu G; Zhao J
    Biomed Pharmacother; 2018 Oct; 106():890-895. PubMed ID: 30119259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The emerging role of lncRNAs in the regulation of osteosarcoma stem cells.
    Song XJ; Bi MC; Zhu QS; Liu XL
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):966-974. PubMed ID: 35179763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA FGFR3-AS1 promotes osteosarcoma growth through regulating its natural antisense transcript FGFR3.
    Sun J; Wang X; Fu C; Wang X; Zou J; Hua H; Bi Z
    Mol Biol Rep; 2016 May; 43(5):427-36. PubMed ID: 27022737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long Non-Coding RNA
    Lee AM; Ferdjallah A; Moore E; Kim DC; Nath A; Greengard E; Huang RS
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA AFAP1‑AS1 enhances cell proliferation and invasion in osteosarcoma through regulating miR‑4695‑5p/TCF4‑β‑catenin signaling.
    Li R; Liu S; Li Y; Tang Q; Xie Y; Zhai R
    Mol Med Rep; 2018 Aug; 18(2):1616-1622. PubMed ID: 29901121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long noncoding RNA OIP5-AS1 accelerates CDK14 expression to promote osteosarcoma tumorigenesis via targeting miR-223.
    Dai J; Xu L; Hu X; Han G; Jiang H; Sun H; Zhu G; Tang X
    Biomed Pharmacother; 2018 Oct; 106():1441-1447. PubMed ID: 30119217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The multiple function of long noncoding RNAs in osteosarcoma progression, drug resistance and prognosis.
    Xu S; Gong Y; Yin Y; Xing H; Zhang N
    Biomed Pharmacother; 2020 Jul; 127():110141. PubMed ID: 32334375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNAs in prostate cancer: overview and clinical implications.
    Malik B; Feng FY
    Asian J Androl; 2016; 18(4):568-74. PubMed ID: 27072044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpressing circular RNA hsa_circ_0002052 impairs osteosarcoma progression via inhibiting Wnt/β-catenin pathway by regulating miR-1205/APC2 axis.
    Wu Z; Shi W; Jiang C
    Biochem Biophys Res Commun; 2018 Aug; 502(4):465-471. PubMed ID: 29852168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
    Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcoma.
    Sun XH; Yang LB; Geng XL; Wang R; Zhang ZC
    Int J Clin Exp Pathol; 2015; 8(3):2994-3000. PubMed ID: 26045809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined over-expression of the hypoxia-inducible factor 2α gene and its long non-coding RNA predicts unfavorable prognosis of patients with osteosarcoma.
    Li W; He X; Xue R; Zhang Y; Zhang X; Lu J; Zhang Z; Xue L
    Pathol Res Pract; 2016 Oct; 212(10):861-866. PubMed ID: 27623205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.